Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · MEDIFAST INC (MED)

Medifast to rebrand OPTAVIA as Trilivy, a metabolic health system, announced July 17

Neutral Impact 3 of 5 product/contract Written later

Medifast, Inc. announced on July 17, 2026 that its wholly owned subsidiary OPTAVIA is being rebranded as Trilivy, described as a comprehensive metabolic health system. The company also introduced newly formulated meal replacements, with the planned debut of these Fuelings in August. The filing, which furnishes a press release, includes no revenue, earnings, or guidance figures, so its direct financial effect on shareholders is not quantified.

Key points

  • Rebranding of OPTAVIA to Trilivy announced July 17, 2026, via a press release furnished as Exhibit 99.1
  • Trilivy Reset Fueling line, enhanced with MetaVantage Technology, accompanies the brand launch
  • Newly formulated meal replacements, called Fuelings, are planned to debut in August
  • The filing contains no financial results, guidance, or dollar figures

The filing

CompanyMEDIFAST INC (MED)
Form8-K, current report
Filed with the SECJul 17, 2026, 8:33 AM ET
Accession number0001628280-26-048574

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:29 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 17, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.